Effects of novel Coronavirus (COVID-19) on presentation, management, and outcomes of acute cholecystitis at an academic tertiary care center cholecystitis management during COVID-19
Background: The COVID-19 pandemic necessitated adjustments to nearly all aspects of healthcare, including surgical care. The effects of these adjustments have not been well studied on acute surgical problems conventionally managed non-electively in large, tertiary care centers. Methods: A retrospect...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-11-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844023092514 |
_version_ | 1797429726237687808 |
---|---|
author | Nicholas V. Peters Rick O'Connor Bishwajit Bhattacharya John W. Kunstman |
author_facet | Nicholas V. Peters Rick O'Connor Bishwajit Bhattacharya John W. Kunstman |
author_sort | Nicholas V. Peters |
collection | DOAJ |
description | Background: The COVID-19 pandemic necessitated adjustments to nearly all aspects of healthcare, including surgical care. The effects of these adjustments have not been well studied on acute surgical problems conventionally managed non-electively in large, tertiary care centers. Methods: A retrospective analysis of admitted patients with acute cholecystitis at a US academic tertiary care center was performed. We compared the presentation, management, and 30-day outcomes of patients admitted during a 2-month time period during early COVID, to a pre-COVID control group of admitted cholecystitis patients over a 2-month span. Results: The study cohort captured 24 patients, while the control cohort encompassed 53 patients. A non-significant trend toward non-operative management in the COVID cohort is reported. There was no delay in time-to-surgery or complication rate. No surgically managed patient developed COVID within 30 days of operation. Conclusions: Operative management of acute cholecystitis during the COVID-19 pandemic, with pre-operative testing and personal protective equipment guidelines, remained safe and effective. |
first_indexed | 2024-03-09T09:18:16Z |
format | Article |
id | doaj.art-e73f3496532f41468a0d73b0e8faddad |
institution | Directory Open Access Journal |
issn | 2405-8440 |
language | English |
last_indexed | 2024-03-09T09:18:16Z |
publishDate | 2023-11-01 |
publisher | Elsevier |
record_format | Article |
series | Heliyon |
spelling | doaj.art-e73f3496532f41468a0d73b0e8faddad2023-12-02T07:05:01ZengElsevierHeliyon2405-84402023-11-01911e22043Effects of novel Coronavirus (COVID-19) on presentation, management, and outcomes of acute cholecystitis at an academic tertiary care center cholecystitis management during COVID-19Nicholas V. Peters0Rick O'Connor1Bishwajit Bhattacharya2John W. Kunstman3Yale School of Medicine, Department of Surgery, PO Box 208062, New Haven, CT 06520, USAYale School of Medicine, Department of Surgery, PO Box 208062, New Haven, CT 06520, USAYale School of Medicine, Department of Surgery, PO Box 208062, New Haven, CT 06520, USA; VA Connecticut Medical Center, Department of Surgery, Bldg 1, 4th Floor, 950 Campbell Avenue, West Haven, CT 06516, USAYale School of Medicine, Department of Surgery, PO Box 208062, New Haven, CT 06520, USA; VA Connecticut Medical Center, Department of Surgery, Bldg 1, 4th Floor, 950 Campbell Avenue, West Haven, CT 06516, USA; Corresponding author. Department of Surgery, Division of Surgical Oncology Yale University School of Medicine. 310 Cedar Street, FMB 130 New Haven, CT, 06520-8062, USA.Background: The COVID-19 pandemic necessitated adjustments to nearly all aspects of healthcare, including surgical care. The effects of these adjustments have not been well studied on acute surgical problems conventionally managed non-electively in large, tertiary care centers. Methods: A retrospective analysis of admitted patients with acute cholecystitis at a US academic tertiary care center was performed. We compared the presentation, management, and 30-day outcomes of patients admitted during a 2-month time period during early COVID, to a pre-COVID control group of admitted cholecystitis patients over a 2-month span. Results: The study cohort captured 24 patients, while the control cohort encompassed 53 patients. A non-significant trend toward non-operative management in the COVID cohort is reported. There was no delay in time-to-surgery or complication rate. No surgically managed patient developed COVID within 30 days of operation. Conclusions: Operative management of acute cholecystitis during the COVID-19 pandemic, with pre-operative testing and personal protective equipment guidelines, remained safe and effective.http://www.sciencedirect.com/science/article/pii/S2405844023092514COVIDAcute care surgeryPerioperative management |
spellingShingle | Nicholas V. Peters Rick O'Connor Bishwajit Bhattacharya John W. Kunstman Effects of novel Coronavirus (COVID-19) on presentation, management, and outcomes of acute cholecystitis at an academic tertiary care center cholecystitis management during COVID-19 Heliyon COVID Acute care surgery Perioperative management |
title | Effects of novel Coronavirus (COVID-19) on presentation, management, and outcomes of acute cholecystitis at an academic tertiary care center cholecystitis management during COVID-19 |
title_full | Effects of novel Coronavirus (COVID-19) on presentation, management, and outcomes of acute cholecystitis at an academic tertiary care center cholecystitis management during COVID-19 |
title_fullStr | Effects of novel Coronavirus (COVID-19) on presentation, management, and outcomes of acute cholecystitis at an academic tertiary care center cholecystitis management during COVID-19 |
title_full_unstemmed | Effects of novel Coronavirus (COVID-19) on presentation, management, and outcomes of acute cholecystitis at an academic tertiary care center cholecystitis management during COVID-19 |
title_short | Effects of novel Coronavirus (COVID-19) on presentation, management, and outcomes of acute cholecystitis at an academic tertiary care center cholecystitis management during COVID-19 |
title_sort | effects of novel coronavirus covid 19 on presentation management and outcomes of acute cholecystitis at an academic tertiary care center cholecystitis management during covid 19 |
topic | COVID Acute care surgery Perioperative management |
url | http://www.sciencedirect.com/science/article/pii/S2405844023092514 |
work_keys_str_mv | AT nicholasvpeters effectsofnovelcoronaviruscovid19onpresentationmanagementandoutcomesofacutecholecystitisatanacademictertiarycarecentercholecystitismanagementduringcovid19 AT rickoconnor effectsofnovelcoronaviruscovid19onpresentationmanagementandoutcomesofacutecholecystitisatanacademictertiarycarecentercholecystitismanagementduringcovid19 AT bishwajitbhattacharya effectsofnovelcoronaviruscovid19onpresentationmanagementandoutcomesofacutecholecystitisatanacademictertiarycarecentercholecystitismanagementduringcovid19 AT johnwkunstman effectsofnovelcoronaviruscovid19onpresentationmanagementandoutcomesofacutecholecystitisatanacademictertiarycarecentercholecystitismanagementduringcovid19 |